Abstract |
While nonpharmacologic strategies can help patients understand and accept the diagnosis of fibromyalgia, pharmacologic therapy can provide important additional symptom relief and improvement in functioning. Pharmacologic therapy must be individualized based on a comprehensive evaluation of the patient and continued assessment of symptoms and response to treatment. Patient symptoms and impairments related to each of the dimensions of the " fibromyalgia triad" ( pain, sleep dysfunction, and mood disorders) as well as any other comorbidities, past experiences with treatment, and patient preferences should guide therapy selection.
|
Authors | Larry Culpepper |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 71
Issue 12
Pg. e34
(Dec 2010)
ISSN: 1555-2101 [Electronic] United States |
PMID | 21190634
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © Copyright 2010 Physicians Postgraduate Press, Inc. |
Topics |
- Comorbidity
- Fibromyalgia
(drug therapy, epidemiology, psychology)
- Humans
- Mood Disorders
(drug therapy, epidemiology, psychology)
- Pain
(drug therapy, epidemiology)
- Patient Preference
(psychology)
- Sleep Wake Disorders
(drug therapy, epidemiology, psychology)
- Treatment Outcome
|